Jennison Associates LLC increased its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) by 48.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,034,702 shares of the life sciences company’s stock after purchasing an additional 336,930 shares during the period. Jennison Associates LLC owned 1.32% of Integra LifeSciences Holdings Corporation worth $52,232,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of IART. Acrospire Investment Management LLC raised its position in Integra LifeSciences Holdings Corporation by 280.0% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,900 shares of the life sciences company’s stock worth $104,000 after purchasing an additional 1,400 shares during the last quarter. Riverhead Capital Management LLC raised its position in Integra LifeSciences Holdings Corporation by 49.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,399 shares of the life sciences company’s stock worth $131,000 after purchasing an additional 799 shares during the last quarter. LS Investment Advisors LLC raised its position in Integra LifeSciences Holdings Corporation by 4.6% in the 2nd quarter. LS Investment Advisors LLC now owns 2,523 shares of the life sciences company’s stock worth $138,000 after purchasing an additional 111 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Integra LifeSciences Holdings Corporation by 8.6% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,752 shares of the life sciences company’s stock worth $150,000 after purchasing an additional 218 shares during the last quarter. Finally, Whittier Trust Co. bought a new position in Integra LifeSciences Holdings Corporation in the 3rd quarter worth approximately $169,000. Hedge funds and other institutional investors own 83.60% of the company’s stock.

WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.watchlistnews.com/integra-lifesciences-holdings-corporation-iart-shares-bought-by-jennison-associates-llc/1702275.html.

In other news, Director Barbara B. Hill purchased 10,768 shares of the firm’s stock in a transaction dated Tuesday, October 31st. The stock was bought at an average price of $46.66 per share, with a total value of $502,434.88. Following the acquisition, the director now directly owns 55,540 shares of the company’s stock, valued at $2,591,496.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 21.50% of the stock is owned by insiders.

IART has been the subject of a number of analyst reports. Zacks Investment Research raised shares of Integra LifeSciences Holdings Corporation from a “hold” rating to a “buy” rating and set a $57.00 target price for the company in a report on Tuesday, October 3rd. Raymond James Financial, Inc. lifted their target price on shares of Integra LifeSciences Holdings Corporation from $51.00 to $55.00 and gave the stock an “outperform” rating in a report on Thursday, July 27th. TheStreet lowered shares of Integra LifeSciences Holdings Corporation from a “b” rating to a “c+” rating in a report on Thursday, October 26th. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating on shares of Integra LifeSciences Holdings Corporation in a report on Wednesday, July 26th. Finally, J P Morgan Chase & Co lowered shares of Integra LifeSciences Holdings Corporation from an “overweight” rating to a “neutral” rating and set a $44.00 target price for the company. in a report on Friday, October 27th. Seven research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $53.82.

Integra LifeSciences Holdings Corporation (IART) opened at $47.88 on Tuesday. Integra LifeSciences Holdings Corporation has a fifty-two week low of $37.71 and a fifty-two week high of $56.42. The stock has a market cap of $3,734.74, a price-to-earnings ratio of 26.29, a PEG ratio of 2.07 and a beta of 0.64. The company has a debt-to-equity ratio of 1.26, a current ratio of 4.49 and a quick ratio of 3.39.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) last announced its quarterly earnings results on Thursday, October 26th. The life sciences company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.02). Integra LifeSciences Holdings Corporation had a net margin of 4.52% and a return on equity of 16.35%. The firm had revenue of $278.83 million during the quarter, compared to analyst estimates of $286.00 million. During the same period last year, the firm earned $0.93 EPS. Integra LifeSciences Holdings Corporation’s quarterly revenue was up 11.4% on a year-over-year basis. sell-side analysts expect that Integra LifeSciences Holdings Corporation will post 1.87 earnings per share for the current fiscal year.

Integra LifeSciences Holdings Corporation Profile

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including product portfolio used in the neurosurgery operating suite and critical care unit, and Orthopedics and Tissue Technologies, which includes differentiated soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement solutions.

Want to see what other hedge funds are holding IART? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integra LifeSciences Holdings Corporation (NASDAQ:IART).

Institutional Ownership by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Receive News & Ratings for Integra LifeSciences Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences Holdings Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.